Primary Myelofibrosis (PMF) Recruiting Phase 1 Trials for Talazoparib (DB11760)

Also known as: Primary Myelofibrosis / Primary Myelofibrosis (MF) / Myelofibrosis (PMF) / Myelofibrosis, Primary / PMF / Osteomyelofibrosis / Primary myelofibrosis (disorder) / Myelofibrosis (disorder) / Primary myelofibrosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0044387 (Primary Myelofibrosis (PMF))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06218628Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 InhibitionTreatment